BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25563170)

  • 1. HPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cells.
    Liu C; Lin J; Li L; Zhang Y; Chen W; Cao Z; Zuo H; Chen C; Kee K
    Sci Rep; 2015 Jan; 5():7653. PubMed ID: 25563170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer.
    Han MS; Lee JM; Kim SN; Kim JH; Kim HS
    Biomed Res Int; 2018; 2018():1942867. PubMed ID: 30627542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.
    Liu F; Zhang S; Zhao Z; Mao X; Huang J; Wu Z; Zheng L; Wang Q
    Oncotarget; 2016 Apr; 7(15):19666-79. PubMed ID: 26910911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo.
    Liao S; Deng D; Zhang W; Hu X; Wang W; Wang H; Lu Y; Wang S; Meng L; Ma D
    Oncol Rep; 2013 Jan; 29(1):95-102. PubMed ID: 23128977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of miR-20a by HPV16 E6 exerts growth-promoting effects by targeting PDCD6 in cervical carcinoma cells.
    Liu X
    Biomed Pharmacother; 2018 Jun; 102():996-1002. PubMed ID: 29710555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
    Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
    Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
    Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
    Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between nitric oxide in cervical microenvironment and different HPV types and effect on cervical cancer cells].
    Wei XM; Wang Q; Gao SJ; Sui L
    Zhonghua Fu Chan Ke Za Zhi; 2011 Apr; 46(4):260-5. PubMed ID: 21609578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
    Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
    Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial microRNAs against the viral E6 protein provoke apoptosis in HPV positive cancer cells.
    Bonetta AC; Mailly L; Robinet E; Travé G; Masson M; Deryckere F
    Biochem Biophys Res Commun; 2015 Oct; 465(4):658-64. PubMed ID: 26241675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis.
    Xu J; Fang Y; Wang X; Wang F; Tian Q; Li Y; Xie X; Cheng X; Lu W
    Oncotarget; 2016 May; 7(21):31520-33. PubMed ID: 27153550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical detection of HPV16 E7 in cervical smear.
    Jeon JH; Shin DM; Cho SY; Song KY; Park NH; Kang HS; Kim YD; Kim IG
    Exp Mol Med; 2007 Oct; 39(5):621-8. PubMed ID: 18059138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition.
    Ranieri D; Belleudi F; Magenta A; Torrisi MR
    Int J Cancer; 2015 Jul; 137(1):61-72. PubMed ID: 25450802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulation of microRNAs Let-7a and miR-21 mediate aberrant STAT3 signaling during human papillomavirus-induced cervical carcinogenesis: role of E6 oncoprotein.
    Shishodia G; Verma G; Srivastava Y; Mehrotra R; Das BC; Bharti AC
    BMC Cancer; 2014 Dec; 14():996. PubMed ID: 25539644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions.
    Sommerova L; Anton M; Bouchalova P; Jasickova H; Rak V; Jandakova E; Selingerova I; Bartosik M; Vojtesek B; Hrstka R
    Antiviral Res; 2019 Mar; 163():185-192. PubMed ID: 30711417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulator role of HPV E7 protein on miR-21 expression in cervical carcinoma cells and its functional implication.
    Kong Q; Wang W; Li P
    Int J Clin Exp Pathol; 2015; 8(12):15808-13. PubMed ID: 26884851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of the malignant phenotype of cervical cancer CaSki cells through adeno-associated virus-mediated delivery of HPV16 E7 antisense RNA.
    Wu S; Meng L; Wang S; Wang W; Xi L; Tian X; Chen G; Wu Y; Zhou J; Xu G; Lu Y; Ma D
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2032-7. PubMed ID: 16609012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.
    Li L; Xu C; Long J; Shen D; Zhou W; Zhou Q; Yang J; Jiang M
    Oncotarget; 2015 Sep; 6(27):23930-43. PubMed ID: 26329329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.